CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $953,000 | +85.4% | 15,649 | +24.7% | 0.01% | +50.0% |
| Q3 2019 | $514,000 | -2.5% | 12,545 | +12.5% | 0.00% | 0.0% |
| Q2 2019 | $527,000 | +33.4% | 11,151 | +1.1% | 0.00% | +33.3% |
| Q1 2019 | $395,000 | +33.0% | 11,034 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $297,000 | -21.8% | 10,406 | +21.7% | 0.00% | 0.0% |
| Q3 2018 | $380,000 | +104.3% | 8,551 | +110.9% | 0.00% | +50.0% |
| Q2 2018 | $186,000 | 0.0% | 4,054 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $186,000 | +745.5% | 4,054 | +334.0% | 0.00% | – |
| Q4 2017 | $22,000 | +100.0% | 934 | +47.3% | 0.00% | – |
| Q3 2017 | $11,000 | +450.0% | 634 | +534.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |